EUVIMEDEUVIMED entdecken
Crossref

Successful Use of Sutimlimab in two Pediatric Patients With Refractory Cold Antibody‐Mediated Autoimmune Hemolytic Anemia

Sibgha Zaheer iD, Rachel Friedmann, Kimberly Cheng iD, Guy Young iD, Christopher Denton iD, Taylor Kim iD

Pediatric Blood & Cancer · 12.10.2026

DOI: 10.1002/1545-5017.70751 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 12.10.2026. Verfasst von Sibgha Zaheer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital Los Angeles, Los Angeles, California, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cold antibody‐mediated autoimmune hemolytic anemia, or cold agglutinin syndrome (CAS), in pediatrics is typically transient, although it can often be severe and require transfusion support. Recurrence in children is rare, but those with underlying immune dysfunction can have a refractory course with limited options available. We report a 4‐year‐old girl with Evans syndrome and life‐threatening CAS refractory to transfusions, plasmapheresis, steroids, and immunosuppression as well as a 12‐month‐old boy status post liver transplant with CAS refractory to steroids, rituximab, and tacrolimus cessation with transition to sirolimus, both of whom received sutimlimab, a C1s inhibitor, with rapid improvement in hemolysis, transfusion independence, and a sustained remission. To our knowledge, these are the first reported uses of sutimlimab in the pediatric population.

Schlagwörter

Stichwörter der Autor:innen

Evans syndromecold antibody‐mediated autoimmune hemolytic anemiacomplement inhibitionimmune dysregulationpediatric autoimmune hemolytic anemia (AIHA)refractory hemolysissutimlimab

Autor:innen und Institutionen

  • Children's Hospital Los Angeles, Los Angeles, California, USA.
  • University of Southern California Keck School of Medicine, Los Angeles, California, USA.
  • Seattle Children's Hospital, Seattle, Washington, USA.

ORCID-Profile: Sibgha Zaheer, Kimberly Cheng, Guy Young, Christopher Denton, Taylor Kim

Zitieren

APA

Zaheer, S., Friedmann, R., Cheng, K., Young, G., Denton, C., & Kim, T. (2026). Successful Use of Sutimlimab in two Pediatric Patients With Refractory Cold Antibody‐Mediated Autoimmune Hemolytic Anemia. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70751

Vancouver

Zaheer S, Friedmann R, Cheng K, Young G, Denton C, Kim T. Successful Use of Sutimlimab in two Pediatric Patients With Refractory Cold Antibody‐Mediated Autoimmune Hemolytic Anemia. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70751

BibTeX
@article{Zaheer2026,
  author = {Zaheer, Sibgha and Friedmann, Rachel and Cheng, Kimberly and Young, Guy and Denton, Christopher and Kim, Taylor},
  title = {Successful Use of Sutimlimab in two Pediatric Patients With Refractory Cold Antibody‐Mediated Autoimmune Hemolytic Anemia},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  doi = {10.1002/1545-5017.70751}
}
Kostenlos starten →